Renaissance Technologies
AMED

Renaissance Technologies’s Amedisys AMED Stock Holding History

Renaissance Technologies’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-364,098
Closed -$35.8M – 3478
2025
Q2 		$35.8M Buy
364,098
+329,198
+943% +$31.1M 0.05% 458
2025
Q1 		$3.23M Sell
34,900
-900
-3% -$83K ﹤0.01% 1705
2024
Q4 		$3.25M Sell
35,800
-84,301
-70% -$7.74M ﹤0.01% 1721
2024
Q3 		$11.6M Sell
120,101
-8,100
-6% -$790K 0.02% 967
2024
Q2 		$11.8M Sell
128,201
-40,600
-24% -$3.77M 0.02% 831
2024
Q1 		$15.6M Sell
168,801
-44,854
-21% -$4.2M 0.02% 755
2023
Q4 		$20.3M Buy
+213,655
New +$20M 0.03% 614
2021
Q4 		– Sell
-38,301
Closed -$5.71M – 3876
2021
Q3 		$5.71M Sell
38,301
-2,100
-5% -$437K 0.01% 1381
2021
Q2 		$9.89M Buy
40,401
+24,700
+157% +$6.48M 0.01% 1178
2021
Q1 		$4.16M Sell
15,701
-31,100
-66% -$8.77M 0.01% 1762
2020
Q4 		$13.7M Sell
46,801
-21,400
-31% -$5.49M 0.01% 961
2020
Q3 		$16.1M Hold
68,201
– – 0.02% 850
2020
Q2 		$13.5M Sell
68,201
-100,500
-60% -$18.7M 0.01% 1049
2020
Q1 		$31M Buy
168,701
+113,501
+206% +$20.2M 0.03% 559
2019
Q4 		$9.21M Buy
55,200
+44,100
+397% +$6.56M 0.01% 1496
2019
Q3 		$1.45M Buy
11,100
+6,600
+147% +$859K ﹤0.01% 2435
2019
Q2 		$546K Sell
4,500
-184,601
-98% -$21.9M ﹤0.01% 2959
2019
Q1 		$23.3M Sell
189,101
-93,000
-33% -$11.7M 0.02% 898
2018
Q4 		$33M Buy
282,101
+156,600
+125% +$18.5M 0.04% 606
2018
Q3 		$15.7M Buy
125,501
+96,583
+334% +$10.7M 0.02% 1079
2018
Q2 		$2.47M Buy
+28,918
New +$2.12M ﹤0.01% 2161
2017
Q3 		– Sell
-28,618
Closed -$1.8M – 3182
2017
Q2 		$1.8M Buy
28,618
+3,818
+15% +$222K ﹤0.01% 2315
2017
Q1 		$1.27M Sell
24,800
-237,500
-91% -$11.3M ﹤0.01% 2450
2016
Q4 		$11.2M Sell
262,300
-107,101
-29% -$4.55M 0.02% 1153
2016
Q3 		$17.5M Sell
369,401
-263,600
-42% -$13.2M 0.03% 785
2016
Q2 		$32M Buy
633,001
+2,100
+0.3% +$106K 0.06% 421
2016
Q1 		$30.5M Buy
630,901
+282,600
+81% +$10.9M 0.06% 427
2015
Q4 		$13.7M Buy
348,301
+200,300
+135% +$8.01M 0.03% 774
2015
Q3 		$5.62M Buy
148,001
+30,801
+26% +$1.3M 0.01% 1304
2015
Q2 		$4.66M Buy
117,200
+49,599
+73% +$1.55M 0.01% 1478
2015
Q1 		$1.81M Sell
67,601
-142,200
-68% -$4.01M ﹤0.01% 1987
2014
Q4 		$6.16M Sell
209,801
-49,700
-19% -$1.23M 0.01% 1159
2014
Q3 		$5.23M Sell
259,501
-79,100
-23% -$1.53M 0.01% 1137
2014
Q2 		$5.67M Buy
338,601
+193,921
+134% +$2.75M 0.01% 1151
2014
Q1 		$2.15M Buy
+144,680
New +$2.23M 0.01% 1730

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Renaissance Technologies's AMED Position: Q3 2025 in Review

Renaissance Technologies sold out of Amedisys (AMED) in Q3 2025, closing a stake of 364,098 shares — an estimated $35.8M sold.

Renaissance Technologies first reported a position in AMED in Q1 2014 and held it in 35 quarters. The position peaked at $35.8M in Q2 2025. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Renaissance Technologies reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Renaissance Technologies sold 364,098 Amedisys shares in Q3 2025, an estimated $35.8M.
  • Renaissance Technologies first reported a position in Amedisys in Q1 2014 and held it in 35 quarters.
  • Renaissance Technologies's Amedisys position peaked at $35.8M in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Renaissance Technologies's 13F filing for Q3 2025, filed 13 Nov 2025.